Post-COVID-19 syndrome: persistent neuroimaging changes and symptoms 9 months after initial infection.
Stephanie L GrachRavindra GaneshSteven A MessinaRyan T HurtPublished in: BMJ case reports (2022)
A previously healthy and active middle-aged woman acquired COVID-19 as an occupational exposure with subsequent persistent post-COVID-19 symptoms including headache, dyspnoea on exertion, chest pressure, tachycardia, anosmia, parosmia, persistent myalgia, vertigo, cognitive decline and fatigue. She presented to a tertiary medical centre for further evaluation after 9 months of persistent symptoms and had a largely unremarkable workup with the exception of a persistently elevated monocyte chemoattractant protein 1, blunted cardiovagal response and non-specific scattered areas of low-level hypometabolism at the bilateral frontal, left precuneus, occipital and parietal regions on PET scan.
Keyphrases
- coronavirus disease
- cognitive decline
- sars cov
- sleep quality
- middle aged
- mild cognitive impairment
- computed tomography
- working memory
- healthcare
- positron emission tomography
- immune response
- depressive symptoms
- magnetic resonance
- protein protein
- physical activity
- peripheral blood
- binding protein
- atrial fibrillation
- contrast enhanced